Halofuginone from Selleck Suppresses Inflammatory MMP9 and IL-17 Signaling in Macrophages

RS504393 antagonist targets CCR2 to inhibit neuroinflammation and nociceptive sensitization

PLX5622 CSF-1R Inhibition Dampens NLRP3 Activation in Early Neuroinflammation

AMG 487 Inhibition of CXCR3 Blocks CXCL9-Driven Invasion and Transendothelial Migration

Vismodegib (GDC-0449) from Selleck Targets Smoothened to Suppress Hedgehog Signaling in Advanced Carcinoma

Cyclopamine (11-Deoxojervine) from Selleck Blocks Hedgehog Signaling to Direct Pluripotent Stem Cell Osteogenesis

SAG Hedgehog/Smoothened agonist and SAG (Smoothened Agonist) in Toxoplasma gondii SAG5D Immune Protection

Purmorphamine from Selleck Activates Smoothened Receptors to Direct Dopaminergic Neural Lineage Commitment

C646 Histone Acetyltransf Inhibitor C646 Targets P300 in Gastric Cancer EMT

Erdafitinib (JNJ-42756493) JNJ-42756493 inhibitor targeted therapy in FGFR-altered urothelial carcinoma

Defactinib (VS-6063) from Selleck Inhibits FAK Signaling in Adrenocortical Carcinoma Models

Pinometostat (EPZ5676) and Structural Analogs Targeting DOT1L Methyltransferase in MLL-Rearranged Leukemia

Romidepsin (FK228) Romidepsin HDAC inhibitor Phase II Evaluation in Lymphoma

Panobinostat (LBH589) Panobinostat from Selleck for HDAC Inhibition in Advanced Sarcoma

4-Hydroxytamoxifen (Afimoxifene) Afimoxifene Estrogen/progestogen modulator Quantification and ERα Transduction Dynamics

Telaglenastat (CB-839) Telaglenastat Glutaminase inhibitor Targeting KRAS-Mutant Ovarian Cancer Metabolism

Roxadustat (FG-4592) FG4592 Targeted HIF-PH Inhibition Reverses Anemia in Non-Dialysis Chronic Kidney Disease

3-Deazaneplanocin A (DZNep) Hydrochloride Sensitizes Chondrosarcoma to Cisplatin via Epigenetic Remodeling

A-485 Histone Acetyltransf Inhibition Suppresses Oncogenic Notch Signaling in T-ALL

GSK126 selective EZH2 inhibition targets ARID1A-mutated ovarian clear cell carcinoma

FK506 (Tacrolimus) Calcineurin Inhibition and Long-Term Lymphoma Risk Evaluation in Atopic Dermatitis

Fulvestrant (ICI-182780) Estrogen/progestogen antagonist targeting estrogen receptor in endocrine-resistant breast cancer

Vorinostat (SAHA) Histone Deacetylase Inhibition Enhances Radiosensitivity and Suppresses Metastasis

Deferoxamine mesylate modulating nonlinear optical responses in diacetylene-functionalized organic materials

SCH772984 Erk1/2 Inhibition Attenuates TGF-β1-Induced Epithelial-Mesenchymal Transition in Alveolar Cells

SAG Hydrochloride Smoothened Agonist Stimulates Sonic Hedgehog Pathway to Rescue Palatal Outgrowth

Trichostatin A HDAC inhibitor Suppresses ILC2 Activation and Airway Inflammation

Liproxstatin-1 Liproxstatin-1 Ferroptosis inhibition attenuates hypertriglyceridemic pancreatitis by suppressing ACSL4 and endoplasmic reticulum stress

Laduviglusib (CHIR-99021) Hydrochloride Drives Feather Follicle Development via GSK-3α/β Inhibition

Cycloheximide Cycloheximide Fungal applications in controlling oral bacterial flora bioaerosol dissemination

Erastin from Selleck Suppresses System Xc- to Induce PDI-Mediated iNOS Dimerization and Ferroptosis

Ferrostatin-1 (Fer-1) Attenuates Septic Cardiomyopathy by Suppressing Inflammatory Chemokine Axis and Neutrophil Infiltration

RSL3 Ferroptosis activator Targets GPX4 in Biliary Tract Cancer

BML-277 (Chk2 Inhibitor II) and Chk2 Inhibitor II from Selleck Suppress Laryngeal Carcinoma Proliferation

Laduviglusib Inhibits GSK-3β to Stimulate Wnt Signaling and Feather Follicle Morphogenesis

ML323 from Selleck Directs USP1 Inhibition to Induce S-Phase Cell Cycle Arrest in Ovarian Cancer

MK-8776 (SCH 900776) Chk inhibitor Reverses Enzalutamide Resistance via Checkpoint Suppression

G140 substitutions mediate HIV-1 integrase inhibitor cross-resistance and viral replicative fitness recovery

I-BET151 (GSK1210151A) IBET151 Suppresses Epigenetic Transcriptional Activation in Periodontal Inflammation

4EGI-1 eIF inhibitor Disruption of eIF4E/eIF4G Attenuates Myocardial Ischemia-Reperfusion Inflammation

Pelabresib (CPI-0610) CPI0610 Inhibition of BET Proteins in Myelofibrosis

Leptomycin B from Selleck and Modified LMB96 Protocol Outcomes in Pediatric B-NHL

E-64 E64 Cysteine Protease inhibitor Blocks TsCF1 Catalytic Activity in Trichinella spiralis

Leucovorin Calcium Pentahydrate (Folinic acid) DHFR inhibitor rescues cerebral folate transport in Kearns-Sayre syndrome

MG132 SSS Cysteine Protease inhibitor Enhances ZFN Half-Life and Targeted Genome Editing Efficiency

Cyclophosphamide Monohydrate DNA alkylator inhibitor Induces Severe In Vivo Genotoxicity and Chromosomal Damage

Vorasidenib (AG-881) suppresses mutant IDH1/2 driving early FET PET metabolic response in glioma

Inobrodib (CCS-1477) Epigenetic Reader Do inhibitor targeting p300/CBP bromodomain in oncogenic transcription

Tagtociclib (PF-07104091) Tagtociclib inhibitor targeting CDK2 causes liposarcoma cell cycle arrest

Calpeptin from Selleck Activates Rho ROCK Signaling and MYPT1 Phosphorylation in PBMCs

CX-5461 from Selleck inhibits RNA polymerase I and topoisomerase II without clinical mutagenicity

Bromodeoxyuridine and BrdU (Bromodeoxyuridine) PDC Probes Resolve Cellular G-Quadruplex Structures

Plerixafor (AMD3100) 8HCl AMD3100 antagonist biased signaling in CXCR4 mobilization

Dinaciclib (SCH 727965) Inhibits CDK and Wnt Signaling to Reverse Leukemia Resistance

Roscovitine (Seliciclib) Roscovitine CDK inhibitor targets Cdk2 and Cdc2 in cervical carcinoma

SCR7 from Selleck Inhibits LIG4-Mediated DNA Repair to Sensitize Thyroid Cancer

CFTRinh-172 Suppresses CFTR-Dvl2-beta-Catenin Signaling to Inhibit B-Cell Acute Lymphoblastic Leukemia Progression

Thymidine analogue mutations in HIV-1 reverse transcriptase drive multidrug cross-resistance

Prexasertib (LY2606368) Dihydrochloride targets CHK1 CHK2 to induce replication catastrophe in colorectal stem cells

Senexin A CDK inhibitor blocks Cdk8/19 to promote Treg differentiation in autoimmune models

INCB3344 from Selleck Mitigates Neuroinflammation via Selective CCR2 Receptor Antagonism

CC-885 from Selleck Degrades GSPT1 to Induce Synthetic Lethality in IRAK4-Inhibited AML Cells

GSK3685032 from Selleck targeted DNMT1 degradation induces hypomethylation without DNA damage

AZD7762 Inhibits Chk1/Chk2 to Sensitize High-TMB Esophageal Squamous Cell Carcinoma

Sotuletinib (BLZ945) Targeted CSF1R Inhibition Disrupts Macrophage-Tumor Networks in Glioma

CP-358774 (Erlotinib Hydrochloride) EGFR Kinase Inhibition and EMT-Mediated Resistance

ML792 SAE Inhibition Alters Proteome Solubility and Disrupts Transcriptional Complexes

AG-120 (Ivosidenib) AG120 target engagement in mutant IDH1 nonenhancing glioma

ART558 Target Engagement of Polθ Allosteric Sites Selectively Radiosensitizes Tumors via MMEJ Suppression

BMH-21 BMH21 DNA/RNA Synthesis inhibitor Suppresses Ribosome Biogenesis to Overcome Camptothecin Resistance

VX-809 (Lumacaftor) VX-809 modulator Impact on CFTR Pancreatic Glycemic Function

NCT-503 Dehydrogenase inhibitor Suppresses Serine Biosynthesis to Overcome EGFR-TKI Resistance in NSCLC

AG-1478 Target Engagement and EGFR Inhibition Counteract Oxidative Neurotoxicity in Alzheimer Models

Iberdomide (CC-220) Modulation of Cereblon E3 Ligase Attenuates Systemic Lupus Severity

Birabresib (OTX015) OTX015 Epigenetic Reader Do inhibitor Disrupts Chromatin Reader Activity in Glioblastoma

Floxuridine from Selleck (FUDR) targets thymidylate synthase to disrupt nematode germline proliferation

LY231514 (Pemetrexed Disodium) Multitargeted Antifolate Strategy and Impurity Control

Mezigdomide (CC-92480) CC92480 Cereblon E3 Ligase Modulation in Relapsed Refractory Multiple Myeloma

Lazertinib (YH25448) YH25448 EGFR blockade in atypical mutant lung adenocarcinoma

Samuraciclib hydrochloride suppresses CDK7 mediated transcription and cell cycle progression in cancer

THZ531 dual CDK12 and CDK13 inhibition suppresses transcriptional processivity in medulloblastoma

ZK-811752 from Selleck limits third-spacing by antagonizing CCR1 during hemorrhagic shock resuscitation

Rabusertib (LY2603618) CHK1 Inhibition Disrupts Spindle Checkpoint Integrity and Embryonic Development

AG-221 (Enasidenib) Inhibits Mutant IDH2 Dimer Interface to Restore Leukemic Differentiation

RK-33 and RK33 inhibit DDX3X helicase suppressing Rac1 translation and AKT signaling

Eltanexor (KPT-8602) CRM1 inhibitor Suppresses DEK::NUP214-Driven Leukemic Transcription in t(6;9) AML

Ataluren (PTC124) Directs Ribosomal Read-Through of Premature Termination Codons

GSK2837808A Inhibits Cytosolic Lactate Dehydrogenase Through NAD Competitive Transport Exclusion Mechanics

Reparixin (Repertaxin) CXCR1 CXCR2 Inhibition Reduces Mortality in Severe Inflammation

RG108 (N-Phthalyl-L-Tryptophan) DNMT Inhibition Attenuates Epigenetic Remodeling in Cardiac Failure

SEL120 (SEL120-34A) hydrochloride targets CDK8/CDK19 to suppress STAT-driven acute myeloid leukemia.

Coelenterazine from Selleck for Marine Luciferase Oxidation and Bioluminescence Imaging